Haemoglobinopathy Diagnosis (eBook)
496 Seiten
Wiley-Blackwell (Verlag)
978-1-394-26536-7 (ISBN)
Compact, clearly written, and well-illustrated resource for the laboratory diagnosis of haemoglobin disorders and for understanding the clinical significance of these disorders
Designed as a practical resource and written in a concise and approachable format, Haemoglobinopathy Diagnosis offers a comprehensive review of the practical information needed for an understanding of the laboratory diagnosis of haemoglobin disorders. This revised and updated fourth edition covers the most recent advances in the field with new material on antenatal screening/prenatal diagnostic services, including illustrative examples and helpful questions to aid in information retention, and offers a myriad of self-assessment case studies that are ideal for the trainee.
Written by two leading haematologists, the text is set in a clinical context and focuses on the selection, performance, and interpretation of the tests that are offered by the majority of diagnostic laboratories.
Haemoglobinopathy Diagnosis discusses topics including:
- Genetics of haemoglobin synthesis and laboratory techniques for the identification of abnormalities of globin chain synthesis
- Thalassaemias and related conditions, and sickle cell haemoglobin and its interactions with thalassaemias with other variant haemoglobins
- Acquired abnormalities of globin chain synthesis or haemoglobin structure and organization of a haemoglobinopathy diagnostic service
- Situations when more specialist tests are required and what specialist referral centres will help to accomplish
Written for trainees in haematology, practicing haematologists, laboratory scientists, and professionals in the pharmaceutical and diagnostics industries, the Fourth Edition of Haemoglobinopathy Diagnosis is an essential reference and learning tool that provides a clear basis for understanding the diagnosis of haemoglobin disorders.
Barbara J. Bain, Professor of Diagnostic Haematology, Imperial College London and Honorary Consultant Haematologist, Imperial College Healthcare NHS trust, St Mary's Hospital, London, UK.
David C. Rees, Professor of Paediatric Haematology and Consultant in Paediatric Haematology, Department of Haematological Medicine, King's College London, King's College Hospital, Denmark Hill, London, UK.
Abbreviations and glossary
- α
- the Greek letter alpha
- α chain
- the α globin chain, which is required for synthesis of haemoglobins A, F and A2 and also the embryonic haemoglobin, Gower 2
- α gene
- one of a pair of genes on chromosome 16, HBA1 and HBA2, that encode α globin
- α thalassaemia
- a group of thalassaemias characterised by absent or reduced α globin chain synthesis, usually resulting from deletion of one or more of the α globin genes; less often it results from altered structure of an α gene or mutation of the locus control gene, LCRA, or genes encoding trans‐acting factors
- α0 thalassaemia
- a thalassaemic condition in which there is no α globin chain translation from one or both copies of chromosome 16
- α+ thalassaemia
- a thalassaemic condition in which there is reduced but not absent translation of α globin chain from one or both copies of chromosome 16
- β
- the Greek letter beta
- β chain
- the β globin chain, which forms part of haemoglobin A and haemoglobin Portland 2 and is the only globin chain in the abnormal haemoglobin, haemoglobin H
- β gene
- the gene on chromosome 11, HBB, that encodes β globin
- β thalassaemia
- a thalassaemia characterised by reduced β globin synthesis, usually caused by mutation of a β globin gene; less often it results from gene deletion or from deletion or mutation of the locus control region, LCRB
- β thalassaemia intermedia
- a β thalassaemia with significant clinicopathological abnormalities but not dependent on transfusion for survival; also known as non‐transfusion‐dependent thalassaemia
- β thalassaemia major
- a β thalassaemia with significant clinicopathological abnormalities, requiring transfusion to sustain life
- γ
- the Greek letter gamma
- γ chain
- the γ globin chain which forms part of fetal haemoglobin (haemoglobin F) and the embryonic haemoglobin, haemoglobin Portland 1, and is the only globin chain in the abnormal variant, haemoglobin Bart's
- γ gene
- one of a pair of very similar genes on chromosome 11, HBG1 and HBG2, encoding γ globin chain
- γ thalassaemia
- a thalassaemic condition resulting from reduced synthesis of γ globin chain
- δ
- the Greek letter delta
- δ chain
- a β‐like globin chain, which forms part of haemoglobin A2
- δ gene
- a gene of the β cluster on chromosome 11, HBD, that encodes δ globin
- δ thalassaemia
- reduced or absent synthesis of δ globin and therefore of haemoglobin A2
- ε
- the Greek letter epsilon
- ε chain
- the ε globin chain, which is synthesised during early embryonic life and forms part of haemoglobins Gower 1 and Gower 2
- ε gene
- a gene of the α globin cluster on chromosome 16, HBE1, that encodes ε globin chain
- ψ
- the Greek letter psi, used to indicate a pseudogene
- ζ
- the Greek letter zeta
- ζ chain
- the ζ globin chain that is synthesised in intrauterine life and that forms part of haemoglobins Gower 1, Portland 1 and Portland 2
- ζ gene
- a gene of the α globin gene cluster on chromosome 16, HBZ, that encodes ζ globin chain
- 2,3 DPG
- 2,3‐diphosphoglycerate; a small molecule that interacts with haemoglobin, decreasing its oxygen affinity
- 3′
- the end of a gene where transcription ceases
- 5′
- the end of a gene where transcription starts
- acquired
- a condition that is not present at birth or is not inherited
- affinity
- the avidity of haemoglobin for oxygen
- AHSP
- α haemoglobin stabilising protein (AHSP)
- AIDS
- acquired immune deficiency syndrome
- ala
- δ‐aminolaevulinic acid, the first compound formed during the process of haem synthesis
- AML
- acute myeloid leukaemia
- ARMS
- amplification refractory mutation system, a PCR technique used, for example, for the detection of mutations causing β thalassaemia; it employs two primer sets, one amplifying normal sequences and one abnormal sequences
- balanced polymorphism
- the stable persistence of two or more alleles of gene in a significant proportion of a population; a potentially deleterious allele may show balanced polymorphism if the heterozygous state conveys an advantage
- base
- a ring‐shaped organic molecule containing nitrogen, which is a constituent of DNA and RNA; DNA contains four bases: adenine, guanine, cytosine and thymine; RNA contains four bases: adenine, guanine, cytosine and uracil
- Bohr effect
- the effect of pH on oxygen affinity; the alkaline Bohr effect is the reduction of oxygen affinity of haemoglobin as pH falls from above to below the physiological pH; there is also an acid Bohr effect which is a rise of oxygen affinity as the pH falls further, at a pH level that is incompatible with life
- bp
- base pair, the pairing of specific bases, e.g. adenine with thymine, in the complementary strands of the DNA double helix
- CAP
- 7‐methyl guanosine cap, added to RNA molecule during processing
- capillary electrophoresis
- electrophoresis within a capillary tube
- carbonic anhydrase
- a red cell enzyme that is the second most abundant red cell protein after haemoglobin; it may be apparent on haemoglobin electrophoretic strips if a protein rather than a haem stain is used
- carboxyhaemoglobin
- haemoglobin that has been chemically altered by combination with carbon monoxide
- CE‐HLPC
- cation‐exchange high performance liquid chromatography; see HPLC
- chromatography
- a method of separating proteins from each other by means of physical characteristics, such as molecular weight, charge or hydrophobicity, or by means of differing affinity for lectins, antibodies or other proteins; in column chromatography the proteins move through an absorbent column and emerge after different periods of time
- cis
- on the same chromosome (see also trans)
- cis‐acting
- a DNA sequence that affects the expression of a gene on the same chromosome but not on the homologous chromosome (see also trans‐acting)
- CNV
- copy number variant
- CO
- carbon monoxide, the molecule composed of one carbon atom and one oxygen atom, formed by combustion of hydrocarbons
- CO2
- carbon dioxide, the molecule composed of one atom of carbon combined with two atoms of oxygen
- codon
- a triplet of nucleotides that encodes a specific amino acid or serves as a termination signal; there are 61 codons encoding 20 amino acids and three codons that act as termination or STOP codons
- congenital
- present at birth, often but not necessarily inherited
- cooperativity
- the interaction between the four globin monomers that makes possible the Bohr effect and the sigmoid shape of the oxygen dissociation curve
- COVID‐19
- corona virus disease 2019
- CT
- computed tomography
- CV
- coefficient of variation
- DCIP test
- a screening test for haemoglobin E using dichlorophenolindophenol
- deletion
- loss of part of a chromosome, which may include all or part of a globin gene
- deoxyhaemoglobin
- haemoglobin that is not combined with O2
- DGGE
- denaturing gradient gel electrophoresis, a molecular genetic technique for locating a mutation prior to precise analysis
- DNA
- deoxyribonucleic acid, the major constituent of the nucleus of a cell; a polynucleotide strand that is able to replicate and that codes for the majority of proteins synthesised by the cell; the DNA molecule is a double helix of two complementary intertwined polynucleotides
- EDTA
- ethylene diamine tetra‐acetic acid
- eIF2
- erythroid initiation factor 2
- EKLF
- erythroid Krüppel‐like factor
- electrophoresis
- separation of charged suspended particles such as proteins by application to a membrane or gel or within a capillary followed by exposure to a charge gradient, e.g. haemoglobin electrophoresis
- ELISA
- enzyme‐linked immunosorbent assay
- elution
- removal of an absorbed substance from a chromatography column or membrane
- enhancer
- a DNA sequence that influences the promoter of a nearby gene to increase transcription; an enhancer acts on a gene in cis and may be sited...
Erscheint lt. Verlag | 22.11.2024 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Innere Medizin |
Schlagworte | globin chain synthesis • haemoglobin antenatal screening • haemoglobin disorders • haemoglobinopathy diagnostic • haemoglobin prenatal diagnostic services • haemoglobin synthesis • haemoglobin test • sickle cell haemoglobin • thalassaemias |
ISBN-10 | 1-394-26536-0 / 1394265360 |
ISBN-13 | 978-1-394-26536-7 / 9781394265367 |
Haben Sie eine Frage zum Produkt? |
Größe: 35,2 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich